Generalized Anxiety Disorder (GAD), Major Depressive Disorder
Conditions
Brief summary
The investigators want to test if gen AI can support therapy by recruiting patients already in therapy.
Detailed description
Recent advancements in AI have led to chatbots, such as ChatGPT, capable of providing therapeutic responses. Early research evaluating chatbots' ability to provide relationship advice and single-session relationship interventions has showed that both laypeople and relationship therapists rate them high on attributes such as empathy and helpfulness. The investigators want to test if chatbots can be a good adjunct to traditional therapy. The investigators hypothesize that participants who regularly use a chatbot as an adjunct to traditional therapy will have better mental health outcomes. Participants will complete baseline, 4-week (post-intervention) and 4-week post-intervention measures and will be invited to gain their therapists ratings.
Interventions
BEHAVIORALChatbot Therapy
This group will be asked to use an AI chatbot like chatgpt as an adjunct to their regular therapy
Sponsors
National Center for Complementary and Integrative Health (NCCIH)
University of California, Irvine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18+ * US Resident * English-speaking * Self-report having been treated for or diagnosed with generalized anxiety disorder or major depressive disorder by a licensed provider (e.g., MD, DO, LPCC, LCSW, LMFT) in the past 12 months * Self-report currently being in individual therapy
Exclusion criteria
* Ever diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, or hospitalized for suicidality
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Generalized Anxiety Disorder (GAD-7) | Baseline, 4-week follow-up, 8-week follow-up | Questions about symptoms of generalized anxiety disorder. Scale is 0-21. Higher scores is a worse outcome. |
| Patient Health Questionnaire (PHQ-9) | Baseline, 4-week follow-up, 8-week follow-up | Questions about symptoms of depression. Scale is 0-27. Higher score is a worse outcome. |
Outcome results
None listed